Ginkgo Bioworks, which is building a leading platform for cell programming and biosecurity, has completed the first milestone under its partnership with Merck, focused on improving biologic manufacturing. As part of this milestone, Ginkgo will receive a research milestone payment of $9 million in cash.   The two companies will now move on to the second stage of this partnership, which will be focused on continuing to improve the production process.   “We’re excited to achieve the...